newsfilter
← Latest News
PR Newswire·

BiondVax to Present at H.C. Wainwright 24th Annual Global Investment Conference

JERUSALEM, Sept. 8, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative products for the prevention and treatment of infectious diseases and ot